← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 30, 2020Last known activity
Oct 1, 2024
Timeline
2010s
- Nov 1, 2018
AnHeart Therapeutics Inc.— Founded
Drugs by trial phase (6 distinct, 10 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT06214793CollaboratorPhase 2Oct 1, 2024
- NCT06564324Lead sponsorPhase 3Sep 30, 2024
- NCT05814536Lead sponsorPhase 1May 6, 2023
- NCT05303519Lead sponsorPhase 2Jan 31, 2023
- NCT05577416CollaboratorEarly Phase 1Oct 11, 2022
- NCT05357820Lead sponsorPhase 1Jul 19, 2021
- NCT05357911Lead sponsorPhase 1Jul 13, 2021
- NCT05357911Study directorPhase 1Jul 13, 2021
- NCT04919811Lead sponsorPhase 2Jun 30, 2021
- NCT04617054Lead sponsorPhase 2Dec 31, 2020
- NCT04395677Lead sponsorPhase 2Jun 30, 2020
Details
- Founded
- Zhejiang,, CN Nov 1, 2018
- Last known activity
- Oct 1, 2024